Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.71% | 30.26 | 14.1% | $178.05m | |
| AMRN | Amarin Corp. Plc | -0.75% | 19.91 | 1.7% | $159.55m | |
| AXSM | Axsome Therapeutics, Inc. | -2.31% | 90.34 | 1.9% | $129.63m | |
| SAVA | Cassava Sciences, Inc. | -4.40% | 8.25 | 0.0% | $91.12m | |
| ARQL | ArQule, Inc. | 0.15% | 20.00 | 0.6% | $78.96m | |
| BHC | Bausch Health Cos., Inc. | 1.71% | 30.26 | 0.0% | $74.96m | |
| SAGE | SAGE Therapeutics, Inc. | 3.12% | 76.40 | 8.6% | $70.78m | |
| GWPH | GW Pharmaceuticals Plc | -0.13% | 118.97 | 6.2% | $70.43m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.36% | 151.05 | 2.3% | $67.88m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.76% | 106.11 | 16.9% | $63.50m | |
| PRGO | Perrigo Co. Plc | -0.82% | 59.02 | 6.8% | $58.61m | |
| HZNP | Horizon Therapeutics Plc | 0.29% | 38.40 | 6.6% | $57.70m | |
| ENDP | Endo International Plc | -2.27% | 6.04 | 8.8% | $42.46m | |
| ICLR | ICON plc | 0.38% | 175.78 | 4.2% | $41.39m | |
| CTLT | Catalent, Inc. | -1.03% | 60.84 | 2.4% | $37.19m |
Company Profile
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases. It's product include, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The firm develops RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, United Kingdom.